SCHEMBL7974056

SCHEMBL7974056

Cc1ccc(Cn2cnc3nc(-c4ccccc4F)[nH]c(=O)c32)cc1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.47
SMN1; SMN2 Q16637 6/20 0.47
ALDH1A1 P00352 3/20 0.47
KMT2A Q03164 4/20 0.46
MEN1 O00255 3/20 0.43
THRB P10828 1/20 0.42
HTT P42858 2/20 0.41
KDM4E B2RXH2 1/20 0.41
ACP1 P24666 1/20 0.40
LMNA P02545 1/20 0.40
CYP11B1 P15538 1/20 0.40
CYP11B2 P19099 1/20 0.40
GAA P10253 1/20 0.38
MET P08581 1/20 0.37
BRD4 O60885 1/20 0.37
CXCR2 P25025 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7988183 0.91 SMN1; SMN2 (0.48) HPGDSMN1; SMN2ALDH1A1KMT2AMEN1
SCHEMBL7974644 0.91 SMN1; SMN2 (0.55) HPGDSMN1; SMN2ALDH1A1KMT2AMEN1
SCHEMBL7974306 0.89 HPGD (0.45) HPGDSMN1; SMN2ALDH1A1KMT2AMEN1
SCHEMBL7984195 0.89 HPGD (0.45) HPGDSMN1; SMN2ALDH1A1KMT2AMEN1
SCHEMBL7984876 0.85 SMN1; SMN2 (0.47) HPGDSMN1; SMN2ALDH1A1KMT2AMEN1
SCHEMBL7973916 0.84 LMNA (0.43) HPGDSMN1; SMN2ALDH1A1KMT2AMEN1
SCHEMBL7984716 0.84 SMN1; SMN2 (0.53) HPGDSMN1; SMN2ALDH1A1KMT2AMEN1
SCHEMBL7988452 0.84 SMN1; SMN2 (0.46) HPGDSMN1; SMN2ALDH1A1KMT2AMEN1
SCHEMBL7974061 0.83 CNOT7 (0.42) HPGDSMN1; SMN2ALDH1A1KMT2AMEN1
SCHEMBL7985164 0.83 KMT2A (0.46) HPGDSMN1; SMN2ALDH1A1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed